The Conversation (0)
Chart
Detailed Quote
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology and oncology. The company promotes its approved products through its hospital, field and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived primarily from the product sales of FDA approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, RediTrex, Sancuso, Vaprisol and Vibativ..
Featured Articles and Interviews
Apr 08, 2025
Top 5 Small-cap Pharma Stocks (Updated April 2025)
Dec 22, 2021
Top NASDAQ Pharma Stocks
Press Releases
See More Press Releases
Alert Options
No alert set
INN Article Notification
Alert Option
You will be notified when this event occurs. No additional settings needed.
